Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Volumn 22, Issue 1, 2016, Pages 106-113

  Janse, Ineke C ^a   Koldijk, Marjolein J ^a   Spekhorst, Lieke M ^a   Vila, Arnau Vich ^a   Weersma, Rinse K ^a   Dijkstra, Gerard ^a   Horváth, Barbara ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Crohn's disease; hidradenitis suppurativa; inflammatory bowel disease; risk factors; ulcerative colitis

Indexed keywords

SPACER DNA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ELOVL7 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC RISK; GENOMICS; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SULT1B1 GENE; SULT1E1 GENE; SUPPURATIVE HIDRADENITIS; ULCERATIVE COLITIS; FOLLOW UP; GENETIC ASSOCIATION STUDY; GENETICS; HIDRADENITIS SUPPURATIVA; NETHERLANDS; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS;

COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HIDRADENITIS SUPPURATIVA; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; SURVEYS AND QUESTIONNAIRES;

EID: 84964664229     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000579     Document Type: Article

References (39)

1. Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366:158-164.
2. Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59:596-601.
3. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.
4. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.
5. van der Zee HH, van der Woude CJ, Florencia EF, et al. Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. Br J Dermatol. 2010;162:195-197.
6. Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009; 23:985-998.
7. van der Zee HH, de Ruiter L, van den Broecke DG, et al. Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: A rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol. 2011;164:1292-1298.
8. Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol. 2007;156:51-56.
9. van Wijk F, Cheroutre H. Mucosal T cells in gut homeostasis and inflammation. Expert Rev Clin Immunol. 2010;6:559-566.
10. Schlapbach C, Hanni T, Yawalkar N, et al. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011;65:790-798.
11. Nazary M, van der Zee HH, Prens EP, et al. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa. Eur J Pharmacol. 2011;672:1-8.
12. Rosenfeld G, Bressler B. The truth about cigarette smoking and the risk of inflammatory bowel disease. Am J Gastroenterol. 2012;107: 1407-1408.
13. Higuchi LM, Khalili H, Chan AT, et al. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012;107:1399-1406.
14. van der Heide F, Dijkstra A, Weersma R, et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2009;15:1199-1207.
15. Chan SS, Luben R, Olsen A, et al. Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol. 2013;108: 575-582.
16. Gao M, Wang PG, Cui Y, et al. Inversa acne (hidradenitis suppurativa): A case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol. 2006;126:1302-1306.
17. Al-Ali FM, Ratnamala U, Mehta TY, et al. Hidradenitis suppurativa (or Acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1-1q25.3 region. Exp Dermatol. 2010;19:851-853.
18. Pink AE, Simpson MA, Brice GW, et al. PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa). J Invest Dermatol. 2011;131:1568-1570.
19. Pan Y, Lin MH, Tian X, et al. Gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis. Dev Cell. 2004;7:731-743.
20. Blok J, Jonkman M, Horvath B. The possible association of hidradenitis suppurativa and Down syndrome: is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link? Br J Dermatol. 2014;170:1375-1377.
21. Savva A, Kanni T, Damoraki G, et al. Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa. Br J Dermatol. 2013;168:311-317.
22. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 1996; 379:821-823.
23. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
24. van der Zee HH, de Winter K, van der Woude CJ, et al. The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease. Br J Dermatol. 2014;171:673-675.
25. Esmann S, Dufour DN, Jemec GB. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions. Br J Dermatol. 2010;163:102-106.
26. Spekhorst LM, Visschedijk MC, Alberts R, et al. Performance of the Montreal classification for inflammatory bowel diseases. World J Gastroenterol. 2014;20:15374-15381.
27. Shah TS, Liu JZ, Floyd JA, et al. optiCall: A robust genotype-calling algorithm for rare, low-frequency and common variants. Bioinformatics. 2012;28:1598-1603.
28. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
29. Halfvarson J, Bodin L, Tysk C, et al. Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767-1773.
30. Yadav S, Varayil JE, Kamal N, et al. Hidradenitis suppurativa in patients with inflammatory bowel disease: A population-based study. Gastroenterology. [published online ahead of print May 5, 2015]. doi: 10.1016/j.cgh. 2015.04.173.
31. Sartorius K, Emtestam L, Jemec GB, et al. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161:831-839.
32. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429.
33. van der Heide F, Dijkstra A, Albersnagel F, et al. Active and passive smoking behaviour and cessation plans of patients with Crohn's disease and ulcerative colitis. J Crohns Colitis. 2010;4:125-131.
34. Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, et al. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther. 2005;22:309-315.
35. Simonart T. Hidradenitis suppurativa and smoking. J Am Acad Dermatol. 2010;62:149-150.
36. Stanley EL, Hume R, Coughtrie MW. Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification. Mol Cell Endocrinol. 2005;240:32-42.
37. Ahima RS, Stanley TL, Khor VK, et al. Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-alpha and SOCS3. J Clin Endocrinol Metab. 2011;96:E1153-E1158.
38. Harrison BJ, Read GF, Hughes LE. Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg. 1988;75:972-975.
39. Tamura K, Makino A, Hullin-Matsuda F, et al. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated longchain fatty acid metabolism. Cancer Res. 2009;69:8133-8140.